Thrombin receptor overexpression in malignant and physiological invasion processes
about
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasisThe placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsiaMolecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.Ovarian cancer, the coagulation pathway, and inflammationG Protein-Coupled Receptors in CancerPlatelets, coagulation and fibrinolysis in breast cancer progressionUnravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approachesCrystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastasesDifferential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissuesEtk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significanceThrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.In vivo nano-imaging of membrane dynamics in metastatic tumor cells using quantum dots.Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging.The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surfaceTissue factor and PAR2 signaling in the tumor microenvironmentThe activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.Tissue factor-factor VIIa signaling.The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growthChapter 12. Placental remodeling of the uterine vasculature.Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.G protein-coupled receptor sorting to endosomes and lysosomes.Comparable ecological dynamics underlie early cancer invasion and species dispersal, involving self-organizing processes.Statins induce hypothrombotic states?Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion.An integrated mathematical model of thrombin-, histamine-and VEGF-mediated signalling in endothelial permeability.Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.Protein targets of inflammatory serine proteases and cardiovascular disease.Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.Rho GTPase-dependent transformation by G protein-coupled receptors.Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1).Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotypeCommon critical pathways in embryogenesis and cancer.Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.Par genes: molecular probes to pathological assessment in breast cancer progressionThe G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis.Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis.A critical role of Gbetagamma in tumorigenesis and metastasis of breast cancer.Identify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chip
P2860
Q24652518-CB57F799-2611-4B79-9F34-5E6ABDFC1F72Q24795491-D4F13D26-3119-4384-B49A-DAA01C6911F8Q24800983-07302288-78E1-4516-BA78-5EEA0F1F1B26Q24816796-940E0B83-5537-44D5-BDF4-4F0716329882Q26741203-410ADD4B-CBD5-4A6F-AF2F-171CA7E422BCQ26823716-95944818-7041-49C6-9D35-44F99BAFCA8BQ27008332-F8132314-FC77-4C3D-B578-81A1F89616B3Q27660263-3029B7B1-5738-476B-AAA3-B504333A5411Q28084420-9F67F5D2-BC44-4265-AF24-8553F1182072Q28366493-8E3192A0-EE51-40FC-BCB3-B39BC35D86FFQ28474456-54192907-14F0-43E9-8718-513D2659AF31Q30413746-7CA30406-9F1E-4169-85EF-675D4A2DC8DBQ30492792-5576E570-C399-46B4-93FB-05DE09E430D9Q30665854-27EBB725-375D-4533-88A5-BE59547A9A91Q30989694-5C463CB9-0A66-41BC-ADCC-5CC774CB1A92Q33585541-5FDD9A3A-9746-4D11-80CB-12B3DA3B69B7Q33592102-92EA455C-8F3D-4784-8CF0-302D37576BC6Q33665441-50AC6639-A3C5-4AC3-B296-479704B12204Q33726774-59C5FE37-B48F-499F-A2F3-71FCFCCB93FAQ33792985-9E9356D4-D9BF-4004-B0C1-E6C23944DBA5Q33801683-58BE1A6B-55ED-48BE-A294-16C14BA2D727Q33830089-75A1FF28-CEFE-4E08-B051-48CEB1E9F223Q33848408-E90768B2-E260-4154-A76F-CEFA29D40CD8Q33865103-B8E01463-F6D3-4264-8D28-55884CDE3A1EQ33868357-242E4EC1-A398-438B-BE0F-70B7512459D7Q33870552-35BD635A-4740-4460-8198-16A123A2C78CQ33960909-F695D43A-04F5-4465-A453-0A67CAC8620BQ34048965-9B2B2949-3E18-401A-B609-51A67C523B8FQ34114355-DB9B7873-9459-4515-A03F-EBE380224A65Q34148307-5147E16D-25FF-4A9C-9EE7-6601491A9546Q34225958-589B928F-C67B-4F8E-8B66-EA926D7D2A33Q34332597-C3B914D7-F88B-4F8F-A581-0CAFF3B3AEC9Q34490721-2608E1CE-B88F-45FA-A606-5E4E38A187FCQ34535747-C6928F0F-DD75-42D6-B91A-EFEF508F642DQ34541646-5031817D-BC68-4934-A44C-53DDFEF39E8DQ34557771-E9452C75-0EF0-4FCB-A2B2-B2D2FA97A7F7Q34650253-96E77CF5-8722-487B-978F-98D93497B062Q34722924-9860D914-AD7B-4ED4-8CAC-8B50341E903CQ34787134-DD5864EB-815F-4366-9D5F-0A50A5AED61FQ35010418-28FAEAF2-5C4E-4CA3-BBA2-1E97BD544A7D
P2860
Thrombin receptor overexpression in malignant and physiological invasion processes
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Thrombin receptor overexpression in malignant and physiological invasion processes
@ast
Thrombin receptor overexpression in malignant and physiological invasion processes
@en
Thrombin receptor overexpression in malignant and physiological invasion processes
@en-gb
Thrombin receptor overexpression in malignant and physiological invasion processes
@nl
type
label
Thrombin receptor overexpression in malignant and physiological invasion processes
@ast
Thrombin receptor overexpression in malignant and physiological invasion processes
@en
Thrombin receptor overexpression in malignant and physiological invasion processes
@en-gb
Thrombin receptor overexpression in malignant and physiological invasion processes
@nl
prefLabel
Thrombin receptor overexpression in malignant and physiological invasion processes
@ast
Thrombin receptor overexpression in malignant and physiological invasion processes
@en
Thrombin receptor overexpression in malignant and physiological invasion processes
@en-gb
Thrombin receptor overexpression in malignant and physiological invasion processes
@nl
P2093
P921
P3181
P356
P1433
P1476
Thrombin receptor overexpression in malignant and physiological invasion processes
@en
P2093
I Vlodavsky
R Bar-Shavit
S Grisaru-Granovsky
Y Ginzburg
P2860
P2888
P304
P3181
P356
10.1038/NM0898-909
P407
P577
1998-08-01T00:00:00Z
P5875
P6179
1013876827